Clinical and pharmacologic risk factors for neuroleptic malignant syndrome: a case–control study
Authors:
- Mario AmoreMAMario Amore
- Paul E KeckPKPaul E Keck
- Mario TroiaMTMario Troia
- Maddalena Dell’aTtiMDMaddalena Dell’aTti
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Biological Psychiatry
- Vol. 44 (8) , 748-754
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Neuroleptic malignant syndromeMedical Clinics of North America, 1993
- Spectrum Concept of Neuroleptic Malignant SyndromeThe British Journal of Psychiatry, 1988
- Neuroleptic malignant syndrome: review and analysis of 115 casesBiological Psychiatry, 1987
- Akathisia Variants and Tardive DyskinesiaArchives of General Psychiatry, 1985
- Pridinolum mesylate and neuroleptic malignant syndromeAmerican Journal of Psychiatry, 1985
- Neuroleptic catatonia and its relationship to psychogenic catatoniaBiological Psychiatry, 1985
- Clinical Characteristics of AkathisiaThe British Journal of Psychiatry, 1983
- Catatonic Reactions to High-Potency Neuroleptic DrugsArchives of General Psychiatry, 1977
- THE CATATONIC SYNDROMEThe Lancet, 1976
- Dose equivalence of the anti-psychotic drugsJournal of Psychiatric Research, 1974